logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yolanda García García

parc tauli hospital universitari
H指数:25
被引数:3,248

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Qualitative study of information needs in advanced ovarian cancer: communication among patients, caregivers and healthcare providers regarding the disease, pharmacological treatment and non-pharmacological support

对晚期卵巢癌信息需求的定性研究：患者、照护者和医疗提供者之间关于疾病、药物治疗和非药物治疗支持方面的沟通

BMJ Open
IF2.3
2026-01-200
OA
Perez, Maria Jesus Rubio; Sanchez-Heras, Ana Beatriz; Alonso, Constanza Maximiano; Garcia, Yolanda Garcia; Oliver, Noelia Alfaro; Corrales, Ruth Marcos; Renau, Raul Rubio; Marsinach, Carlota Sola; Bosque, Soledad Bolea; Varela, Maria Quindos
Sustained long-term responders to niraparib maintenance in recurrent platinum-sensitive high-grade ovarian cancer (PSROC): A subanalysis of the GEICO-88R study

对于复发性铂敏感高级别卵巢癌(PSROC)中接受尼拉帕利维持治疗的长期持续应答者：GEICO-88R研究的一项亚组分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Cueva Banuelos, J. F.; Palacio Vazquez, I.; Maximiano Alonso, C.; Estevez Garcia, P.; Manso Sanchez, L. M.; Constenla Figueiras, M.; Garcia Garcia, Y.; Cros Costa, S.; Salvador Coloma, C.; Santaballa Bertran, A.; Cassinello, J. G.; Corbellas Aparicio, M.; Hernando Polo, S.; De Juan Ferre, A.; Herrero Ibanez, A.; Guerra Alia, E. M.; Fuentes Pradera, J.; Iriarte Moncho, M. E.; Gonzalez-Martin, A.
Phase III MIRASOL trial: Updated overall survival results of mirvetuximab soravtansine (MIRV) vs. investigator's choice chemotherapy (ICC) in patients (pts) with platinum-resistant ovarian cancer (PROC) and high folate receptor-alpha (FRa) expression

III期MIRASOL试验：mirvetuximab soravtansine（MIRV）与研究者选择化疗（ICC）在铂耐药性卵巢癌（PROC）且叶酸受体-α（FRa）高表达患者（pts）中的总生存期更新结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Coffman, L. Gardner; You, B.; Hamilton, E. P.; Garcia, Y. Garcia; Moore, K. N.; Sonnenburg, D.; Scambia, G.; Derio, S.; Pepin, J. Thomes; Klasa-Mazurkiewicz, D.; Tromp, J.; Breuer, S.; Weroha, S.; Sukhina, O.; Wang, Y.; Stec, J. J.; Van Gorp, T.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

Mirvetuximab Soravtansine在fr α 阳性，铂类耐药卵巢癌中的应用

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-12-0761
OA
Moore, K. N.; Angelergues, A.; Konecny, G. E.; Garcia, Y.; Banerjee, S.; Lorusso, D.; Lee, J. -Y.; Moroney, J. W.; Colombo, N.; Roszak, A.; Tromp, J.; Myers, T.; Lee, J. -W.; Beiner, M.; Cosgrove, C. M.; Cibula, D.; Martin, L. P.; Sabatier, R.; Buscema, J.; Estevez-Garcia, P.; Coffman, L.; Nicum, S.; Duska, L. R.; Pignata, S.; Galvez, F.; Wang, Y.; Method, M.; Berkenblit, A.; Roufai, D. Bello; Van Gorp, T.
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme

维持尼拉帕尼治疗铂类敏感性复发性卵巢癌的真实世界安全性和有效性: 西班牙扩大访问计划中的GEICO回顾性观察研究

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-03-016
OA
Cueva, Juan F.; Palacio, Isabel; Churruca, Cristina; Herrero, Ana; Pardo, Beatriz; Constenla, Manuel; Santaballa, Ana; Manso, Luis; Estevez, Purificacin; Maximiano, Constanza; Legeren, Marta; Marquina, Gloria; de Juan, Ana; Quindos, Maria; Sanchez, Luisa; Barquin, Arantzazu; Fernandez, Isaura; Martin, Cristina; Juarez, Asuncin; Martin, Teresa; Garcia, Yolanda; Yubero, Alfonso; Gallego, Alejandro; Bueno, Alejandro Martinez; Guerra, Eva; Gonzalez-Martin, Antonio
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)

奥拉帕尼联合聚乙二醇化脂质体阿霉素治疗铂耐药卵巢癌，无论BRCA状态如何: GEICO II期试验 (ROLANDO研究)

ESMO OPEN
IF8.3
2021-08-0119
OAAI
Perez-Fidalgo, J. A.; Cortes, A.; Guerra, E.; Garcia, Y.; Iglesias, M.; Sarmiento, U. Bohn; Garcia, E. Calvo; Sanchez, L. Manso; Santaballa, A.; Oaknin, A.; Redondo, A.; Rubio, M. J.; Gonzalez-Martin, A.
Randomized, open-label, phase II trial of dostarlimab (TSR-042), as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemo-radiation: ATOMICC study
ANNALS OF ONCOLOGY
IF65.4
2020-09-015
OAAI
Oaknin, A.; Iglesias, M.; Alarcon, J. D.; Villacampa Javierre, G.; Gaba Garcia, L.; Santaballa, A.; Manso, L. M.; Romero, I.; Barretina Ginesta, M. P.; Churruca, C.; Garcia, Y.; Sanchez, A. B.; Marquina, G.; Pardo, B.; Redondo, A.; Rubio, M. J.; Gonzalez Martin, A.
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study
ANNALS OF ONCOLOGY
IF65.4
2018-10-0168
OAAI
Thomas, M.; Ponce-Aix, S.; Navarro, A.; Riera-Knorrenschild, J.; Schmidt, M.; Wiegert, E.; Kapp, K.; Wittig, B.; Mauri, C.; Gomez, M. Domine; Kollmeier, J.; Sadjadian, P.; Froehling, K. -P.; Huber, R. M.; Wolf, M.; Pall, Georg; Surmont, Veerle; Bosquee, Leon; Germonpre, Paul; Brueckl, Wolfgang; Grah, Christina; Herzmann, Christian; Leistner, Rumo; Meyer, Andreas; Mueller, Lothar; Schmalz, Oliver; Scholz, Christian; Schroeder, Michael; Serke, Monika; Wesseler, Claas; Brandts, Christian; Kopp, Hans-Georg; Blau, Wolfgang; Griesinger, Frank; Garcia Campelo, Maria Rosario; Garcia Garcia, Yolanda; Trigo Perez, Jose Manuel

研究方向

暂未获取到该数据
A
Antonio González-Martı́n
H 指数:67论文数:662被引数:3.3万
A
Ana Santaballa
H 指数:25论文数:200被引数:1,752
L
Luís Manso
H 指数:39论文数:451被引数:8,435
A
Abhay Pandit
H 指数:79论文数:533被引数:2.3万
A
Ana Oaknin
H 指数:71论文数:715被引数:3.6万
A
Andrés Redondo
H 指数:45论文数:382被引数:1.5万
M
María Jesús Rubio
H 指数:20论文数:101被引数:1,744
P
Peter Dockery
H 指数:51论文数:285被引数:9,390
M
María Iglesias
H 指数:13论文数:62被引数:749
A
Alfonso Cortés
H 指数:17论文数:71被引数:2,143